Ozempic and the PBS in Australia: Patient Information
Patient information about Ozempic (semaglutide) and PBS eligibility in Australia. TGA-approved for type 2 diabetes only; the TGA has stated promotion for weight loss is not permitted. Not an advertisement and not medical advice.
Australia hub
Australia healthcare cost guides
How this guide was checked
TreatCompare uses published provider fees, official regulator registers, NHS/PBS/Medicare references where relevant, and the methodology described on our methodology page. If a clinic, provider or reader spots information that is out of date, they can use our corrections page. Prices are point-in-time and can change before booking.
Most useful next step
Compare current Weight Loss options
This guide explains the costs. The Australia comparison pages show local prices, Medicare/PBS rules and next actions.
Continue from this guide
Turn this Weight Loss article into a comparison
Article visitors often need one of three routes next: provider prices, a calculator, or a related guide that narrows the decision.
Important information for Australian consumers. Ozempic (semaglutide) is a prescription-only (Schedule 4) medicine in Australia. It is TGA-approved for the management of type 2 diabetes, not for weight management. The TGA has specifically stated that promoting Ozempic for weight loss is not permitted in Australia. This article is general patient information about PBS eligibility — it is not an advertisement, not an offer of sale, and not medical advice.
PBS coverage at a glance
The PBS subsidises Ozempic for eligible patients with type 2 diabetes who meet the current PBS criteria. PBS eligibility is decided by an AHPRA-registered prescriber after a clinical assessment. The current criteria, item codes, co-payment amounts and Safety Net thresholds are published at pbs.gov.au and on Services Australia.
The PBS does not subsidise Ozempic for weight management. Off-label prescribing of any medicine is a clinical decision for an AHPRA-registered prescriber and is not endorsed by the manufacturer or the TGA.
What to ask your prescriber
- Whether you are eligible for Ozempic on the PBS under the current type 2 diabetes criteria.
- Whether other TGA-approved diabetes treatments are appropriate before or alongside Ozempic.
- How follow-up and monitoring will work, including blood tests.
- What the consultation, prescription and pathology costs will be.
- Whether the PBS Safety Net applies to your circumstances.
If you are interested in weight management
Weight management is a separate clinical area. Several medicines are TGA-approved for weight management in Australia; suitability is a clinical decision for an AHPRA-registered prescriber following an assessment. See the weight-management hub for general patient information and the prescriber-verification flow.
This site does not display Australian prescription-medicine prices and does not compare medicines on price. Service-level costs (consultation, follow-up, pathology) are described on the service-cost framework page.
If you have spotted an error
Please tell us via the corrections route.
Australia hub
Australia healthcare cost guides
Data funnel
Help improve Australian healthcare price data
TreatCompare gets more useful when readers send real quotes, providers verify listings, and outdated claims are corrected. Submissions are reviewed before publication.
AU weight-management depth
Compliant Australian depth without prescription-medicine price advertising
Australian weight-management depth should focus on service fees, prescriber checks, PBS/Medicare context and pathway transparency rather than brand-name medicine price tables.
| Search target | Price signal | Depth angle | Next data point |
|---|---|---|---|
| Weight-management service costs | Consultation, follow-up and service-fee components | No brand-name prescription medicine price comparison | Service fee, follow-up cadence and cancellation terms |
| Best online weight-loss programs | Program structure and inclusion checks | Prescriber registration, pharmacy pathway and support model | Provider service inclusions without medicine price inducement |
| Juniper vs Mosh | Service-route comparison only | Consultation model, clinician access and support terms | Non-POM service fee and support comparison |
| PBS and Medicare context | PBS eligibility and consultation rebate context | General consumer information with AHPRA verification | Current PBS status and prescriber-check steps |
Frequently asked questions
Is Ozempic covered by the PBS in Australia?
Yes, Ozempic (semaglutide) is PBS listed for the management of type 2 diabetes for eligible patients who meet the current PBS criteria. It is not PBS subsidised for weight management, and the TGA has specifically stated that promoting Ozempic for weight loss is not permitted in Australia.
Who is eligible for Ozempic on the PBS?
PBS eligibility for Ozempic is set by the current PBS criteria for type 2 diabetes. Eligibility is decided by an AHPRA-registered prescriber using current PBS rules. Check pbs.gov.au for the current criteria and confirm with your prescriber.
What does the PBS Safety Net do?
The PBS Safety Net reduces the cost of PBS-subsidised medicines for individuals and families once annual PBS spending reaches the threshold. The thresholds change; see Services Australia and pbs.gov.au for current figures.
Why does this page not list Ozempic prices?
Ozempic is a prescription-only medicine in Australia. Australian regulations restrict the advertising of prescription medicines to consumers, so TreatCompare does not display Ozempic prices — particularly not in a weight-loss context, where promotion is specifically not permitted.
Get an email when prices change
Free alerts when a new provider lists, or the lower-cost published price falls. Confirm by email; unsubscribe in one click.
We'll send a confirmation link first. No marketing — alerts only. Unsubscribe with one click in any email.
Compare prices from verified providers
Weight Loss Injection Cost UK
Service-cost framework, NHS eligibility, provider checks and patient information for Mounjaro, Wegovy, Ozempic and Nevolat queries.
Lower-Cost Injection Route
NHS access, service fees and provider checks
Mounjaro Price UK Questions
Service fees, NHS access and provider checks
Wegovy Price UK Questions
Service fees, NHS access and dose context
Mounjaro Patient Information
Tirzepatide doses, safety checks and prescriber questions
Wegovy Patient Information
Semaglutide 2.4mg doses, safety checks and NHS route
Related articles
Juniper vs Mosh Australia 2026: Programme Service Comparison
General service-level comparison of Juniper and Mosh weight-management consultation routes in Australia. No prescription-medicine prices. Not an advertisement and not medical advice.
Tirzepatide in Australia: Patient Information
General patient information about tirzepatide (the active ingredient in the brand Mounjaro), a prescription-only weight-management medicine in Australia. Not an advertisement and not medical advice.
Ozempic in Australia: Patient Information
Patient information about Ozempic (semaglutide) in Australia. TGA-approved for type 2 diabetes only; the TGA has stated that promoting Ozempic for weight loss is not permitted in Australia. Not an advertisement and not medical advice.
Pilot vs Mosh Australia 2026: Programme Service Comparison
General service-level comparison of Pilot and Mosh weight-management consultation routes in Australia. No prescription-medicine prices. Not an advertisement and not medical advice.